Our spend
Our priority continues to be to spend as much of
our money as possible on services for people living
with cancer. In 2023, we were again able to increase
Macmillan's charitable expenditure to £184.9 million
(2022: £178.7 million), in line with our strategy to
continue to invest in our services. Our strategic
report on pages 13-57 explains what we did and
what we achieved with the money we spent.
Our agile approach continues to enable us to
respond appropriately to the changing environment
and prioritise spending on services to deliver the
greatest impact to those who need us most.
Our direct grants are one-off payments to help
individuals with the extra costs that living with
cancer can bring. £16.9 million has been spent,
a decrease of £2.2 million from 2022, however
changes to the eligibility criteria were made during
2023 and the amount we offer per individual grant
was reduced to ensure we can reach more people
in need of financial support, resulting in 2,000 more
people being supported this year.
During 2023 we made grant commitments to
partner organisations totalling £71.1 million, a
decrease of £9.3 million from 2022, however we
continued to pay out against grant commitments
which have been made in prior years.
During 2023 we saw some shifts in terms of our
partnerships, with more being invested into the end
of life transformational leaders programme, investing
in new palliative and end of life care leadership
roles that will create capacity and capability at
system level. It is anticipated that approximately
100,000 people affected by cancer across the UK
experience high level emotional needs as a result
of, or exacerbated by, their cancer diagnosis. We
moved to delivering integrated psychological
care in cancer pathways for people living with
cancer, and through our investment, influencing
and engagement in this area, we aim to support
timely and equitable access to appropriate mental
health support. You can find more information
on our work in end of life care and psychological
support from page 32. We also increased
investment in our Community Cancer Champions
project, which aims to develop impactful, scalable
services that increase access to cancer care for
Ethnically Diverse and underserved communities
across the UK. Cancer Champions are a collective of
local community volunteers offering invaluable help
and guidance to people furthest from accessing
cancer support and information. Find out more
about this project on page 53. A list of the grants
made to institutions and partner organisations is
disclosed in a separate publication which is available
on our website.
We continue to invest in marketing our Support Line
to ensure we can help as many people as possible
from the point of diagnosis.
Overall, we saw increased spend on the Support
Line by 7.4% to £24.1 million to ensure we can
continue to increase the number of people
accessing our services.
Choosing to invest in our fundraising means we
can generate more long-term income to enable
us to reach more people living with cancer. This
investment is incorporated in the cost of raising our
income, which was £80.3 million in 2023, marking
a £7.3 million increase on 2022. The increase was
mainly driven by increased spend on lottery
acquisition and continued investment in legacies.
We continue to keep a close eye on all our costs
and fundraising activities, to ensure that we are
maximising our resources.
You'll find more detailed analysis of our charitable
expenditure in note 11 to the financial statements.
61
Environmental, social
and governance review
Financial review
Strategic report
Overview Financial statements Thank you